Directory
>
Harald Hampel Md
Harald Hampel Md
Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs, Neurology | Eisai US
New Jersey, United States
Harald Hampel Md
Summary
Dr. Harald Hampel is a distinguished Chief Medical Officer and Senior Vice President at Eisai Inc., specializing in neurology and neuroscience. With over 25 years of experience, he has led numerous successful clinical trials and scientific research efforts focused on neurodegenerative diseases, particularly Alzheimer's disease. Dr. Hampel is the founding president of the Alzheimer Precision Medicine Initiative and has served in various prestigious academic positions in Europe. His work has garnered multiple awards, reflecting his significant contributions to neuroscience, including 11 patents related to biomarkers. Dr. Hampel's commitment to innovation in medical affairs is evident in his strategic leadership at Eisai, where he oversees global neurology clinical trial programs. His educational background includes an M.D. and Ph.D. from the University of Munich, complemented by an M.Sc. in Hospital Administration. He is recognized as a world expert in Alzheimer's disease, with a robust publication record in the field.
Harald Hampel Md
Work Experience
Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs, Neurology at
Eisai US
January 2022 - Present
Chief Medical Officer, Vice President, Head of Global Medical Affairs, Neurology Business Group at
Eisai US
October 2019 - January 2022
Vice President, Head of Global Medical Affairs, Alzheimer's Disease, Neurology Business Group at
Eisai US
May 2019 - September 2019
Excellence Chair and Full Professor of Neurology at
SORBONNE UNIVERSITE
January 2013 - April 2019
Full Professor & Chair of Psychiatry, Head of Department of Psychiatry and Psychosomatic Medicine at
GOETHE UNIVERSITY (GERMANY) IN VIETNAM
January 2010 - January 2013
Full Professor & Chair of Psychiatry, Consultant in General Adult and Psychiatry of Later Life at
Trinity College Dublin
January 2007 - January 2010
Full Professor & Chair of Psychiatry, Consultant in General Adult and Psychiatry of Later Life at
Ludwig-Maximilians-Universität Munchen
January 2005 - January 2007
Founding Director of the Alzheimer Memorial Clinical and Research Center at
Ludwig-Maximilians-Universität Munchen
January 2001 - January 2005
Assistant Professor & Senior Lecturer at
Lmu Ludwig Maximilians Universitat Munchen
January 1997 - January 2001
Postdoctoral Research Fellow at
The National Institutes of Health
January 1995 - January 1997
Clinical & Chief Resident in Psychiatry, Research Fellow in Neurochemistry at
Lmu Ludwig Maximilians Universitat Munchen
January 1993 - January 1995
Clinical Psychiatry, Neuropsychiatry, Neurology and Neuroscience Research Rotations at
Albert Einstein College Of Medicine
January 1991 - January 1992
Harald Hampel Md
Education
Trinity College Dublin, Professorial Fellow And M.A.
January 2008 - January 2030
Katholische Hochschule Nordrhein-Westfalen Köln (Cologne, Germany), M.Sc.
January 2005 - January 2007
Jung Foundation for Science and Research, Hamburg, Germany
January 1995 - January 1997
Ludwig Maximilian University of Munich, M.D. And Ph.D.
January 1991 - January 1993
Studienstiftung des Deutschen Volkes / German Academic Scholarship Foundation, Academic Award/Scholarship
January 1987 - January 1993
The Mount Desert Island Biological Laboratory (MDI), Salsbury Cove, Maine, USA
January 1993 - January 1993
Universität Witten/Herdecke
January 1986 - January 1990
Columbia University in the City of New York
January 1988 - January 1988
January 1985 - January 1986
Ludwig Maximilian University of Munich
January 1983 - January 1985
University of munich, Doctor Of Medicine - Md
Frequently Asked Questions about Harald Hampel Md
What is Harald Hampel Md email address?
Harald Hampel Md's primary email address is *************@med.uni-muenchen.de. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Harald Hampel Md work for?
Harald Hampel Md is a Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs, Neurology at Eisai US, a company specializing in Biological products, except diagnostic.
Where Harald Hampel Md graduated from?
Harald Hampel Md holds a degree in Medicine from Trinity College Dublin.
How can I directly contact Harald Hampel Md?
To contact Harald Hampel Md directly, you can use the email address *************@med.uni-muenchen.de. Complete contact information is available upon registration with Muraena.
Is Harald Hampel Md an immigrant?
Yes, Harald Hampel Md is an immigrant and currently based in United States
Who is Harald Hampel Md?
Dr. Harald Hampel is a distinguished Chief Medical Officer and Senior Vice President at Eisai Inc., specializing in neurology and neuroscience. With over 25 years of experience, he has led numerous successful clinical trials and scientific research efforts focused on neurodegenerative diseases, particularly Alzheimer's disease. Dr. Hampel is the founding president of the Alzheimer Precision Medicine Initiative and has served in various prestigious academic positions in Europe. His work has garnered multiple awards, reflecting his significant contributions to neuroscience, including 11 patents related to biomarkers. Dr. Hampel's commitment to innovation in medical affairs is evident in his strategic leadership at Eisai, where he oversees global neurology clinical trial programs. His educational background includes an M.D. and Ph.D. from the University of Munich, complemented by an M.Sc. in Hospital Administration. He is recognized as a world expert in Alzheimer's disease, with a robust publication record in the field.
Harald`s contact details
*************@med.uni-muenchen.de
*************@eisai.com
Colleagues
Executive Director
President, Partnership Management Core Functional Unit
Executive Vice President, Purpose & Chief Business Officer
Chief Administrative Officer & Executive Vice President - Integrity
Deputy President & Head Of Precision Chemistry – G2D2
Executive Director. International Product Safety
Executive Director, US Payer Markets (Neurology and Oncology)
Executive Director, Statistical Programming, DHBL-CEG
Executive Director, External Stakeholder Engagement, Ad, Global Medical Affairs, Nbg At Eisai Us
Executive Director, Regulatory Strategy - Oncology